会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • ACTIVE PRINCIPLE FOR MITIGATING UNDESIRED MEDICAL CONDITIONS
    • 有效的原则,用于减轻不利的医疗条件
    • US20130302268A1
    • 2013-11-14
    • US13982492
    • 2012-01-25
    • Tim BowdenKristoffer BergmanThomas StrandLennart Soderberg
    • Tim BowdenKristoffer BergmanThomas StrandLennart Soderberg
    • A61K47/48
    • A61K47/58A61K9/0014A61K31/765A61K31/785A61K31/787A61K47/32A61K47/61A61L26/00
    • A composition for treating or preventing inflammatory-related conditions includes as an active principle a carrier which exhibits a plurality of a scavenger structure capable of mitigating the activity of a mediator of inflammatory-related conditions. The scavenger structure includes a nucleophilic centre complying with the formula X1(—R″—)(—R′)mHnwhere: a) X1 is a single-bonded heteroatom selected amongst N, O and S and exhibits a free electron pair; b) m is 0 or 1 and n is 1 or 2; c) —R″— is a bivalent organic group providing attachment to the carrier via one of its free valences and to X1 at the other free valence; and d) R′— is a monovalent organic group attached to the X1 via its free valence. A method for treating or preventing inflammatory-related conditions in an individual suffering from such conditions includes: providing the composition; and contacting the mediator within or separate from the individual.
    • 用于治疗或预防炎症相关病症的组合物包括作为活性成分的载体,其显示出能够减轻炎性相关病症介质活性的多种清道夫结构。 清除结构包括符合式X1(-R“ - )( - R')mHn的亲核中心,其中:a)X 1是选自N,O和S中的单键合杂原子,并表现出自由电子对; b)m为0或1,n为1或2; c)-R“ - 是通过其自由价之一向载体附着至另一自由价的X1的二价有机基团; 和d)R'是通过其自由价与X1连接的一价有机基团。 用于治疗或预防患有这种病症的个体的炎症相关病症的方法包括:提供组合物; 并且在个体内或与个体分开时将介体接触。
    • 7. 发明授权
    • Active principle for mitigating undesired medical conditions
    • 缓解不良医疗状况的主动原则
    • US09302013B2
    • 2016-04-05
    • US13982492
    • 2012-01-25
    • Tim BowdenKristoffer BergmanThomas EngstrandLennart Soderberg
    • Tim BowdenKristoffer BergmanThomas EngstrandLennart Soderberg
    • A61K47/48A61K31/765A61K31/785
    • A61K47/58A61K9/0014A61K31/765A61K31/785A61K31/787A61K47/32A61K47/61A61L26/00
    • A composition for treating or preventing inflammatory-related conditions includes as an active principle a carrier which exhibits a plurality of a scavenger structure capable of mitigating the activity of a mediator of inflammatory-related conditions. The scavenger structure includes a nucleophilic center complying with the formula X1(—R″—)(—R′)mHn where: a) X1 is a single-bonded heteroatom selected amongst N, O and S and exhibits a free electron pair; b) m is 0 or 1 and n is 1 or 2; c) —R″— is a bivalent organic group providing attachment to the carrier via one of its free valences and to X1 at the other free valence; and d) R′— is a monovalent organic group attached to the X1 via its free valence. A method for treating or preventing inflammatory-related conditions in an individual suffering from such conditions includes: providing the composition; and contacting the mediator within or separate from the individual.
    • 用于治疗或预防炎症相关病症的组合物包括作为活性成分的载体,其显示出能够减轻炎性相关病症介质活性的多种清道夫结构。 清除结构包括符合式X1(-R“ - )( - R')mHn的亲核中心,其中:a)X1是选自N,O和S中的单键合杂原子,并表现出自由电子对; b)m为0或1,n为1或2; c)-R“ - 是一种二价有机基团,其通过其自由价中的一种与另一种游离价的X 1连接至载体; 和d)R'是通过其自由价与X1连接的一价有机基团。 用于治疗或预防患有这种病症的个体的炎症相关病症的方法包括:提供组合物; 并且在个体内或与个体分开时将介体接触。